These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


411 related items for PubMed ID: 25880030

  • 1. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.
    Duvlis S, Popovska-Jankovic K, Arsova ZS, Memeti S, Popeska Z, Plaseska-Karanfilska D.
    J Med Virol; 2015 Sep; 87(9):1578-86. PubMed ID: 25880030
    [Abstract] [Full Text] [Related]

  • 2. Clinical Value of Human Papillomavirus E6/E7 mRNA Detection in Screening for Cervical Cancer in Women Positive for Human Papillomavirus DNA or.
    Han L, Husaiyin S, Zhao F, Rezhake R, Niyazi M.
    Clin Lab; 2018 Sep 01; 64(9):1363-1371. PubMed ID: 30274003
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.
    Wang HY, Lee D, Park S, Kim G, Kim S, Han L, Yubo R, Li Y, Park KH, Lee H.
    Asian Pac J Cancer Prev; 2015 Sep 01; 16(17):7633-40. PubMed ID: 26625774
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening.
    Wang HY, Kim H, Park KH.
    Int J Infect Dis; 2019 Jan 01; 78():22-30. PubMed ID: 30248464
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison Between HPV DNA Testing and HPV E6/E7 MRNA Testing in Women with Squamous Cell Abnormalities of the Uterine Cervix.
    Dabeski D, Duvlis S, Basheska N, Antovska V, Stojovski M, Trajanova M, Dimitrov G, Dabeski A, Gureva-Gjorgievska N.
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 May 01; 40(1):51-58. PubMed ID: 31152639
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS.
    Zhu Y, Ren C, Yang L, Zhang X, Liu L, Wang Z.
    BMC Cancer; 2019 Mar 27; 19(1):271. PubMed ID: 30917784
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the performance of the NucliSENS EasyQ HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix.
    Munkhdelger J, Choi Y, Lee D, Kim S, Kim G, Park S, Choi E, Jin H, Jeon BY, Lee H, Park KH.
    Diagn Microbiol Infect Dis; 2014 Aug 27; 79(4):422-7. PubMed ID: 24856365
    [Abstract] [Full Text] [Related]

  • 14. Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men.
    Silling S, Kreuter A, Hellmich M, Swoboda J, Pfister H, Wieland U.
    J Clin Virol; 2012 Apr 27; 53(4):325-31. PubMed ID: 22261122
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Predictive testing of early cervical pre-cancer by detecting human papillomavirus E6/E7 mRNA in cervical cytologies up to high-grade squamous intraepithelial lesions: diagnostic and prognostic implications.
    Varnai AD, Bollmann M, Bankfalvi A, Speich N, Schmitt C, Griefingholt H, Kovács K, Klozoris C, Bollmann R.
    Oncol Rep; 2008 Feb 27; 19(2):457-65. PubMed ID: 18202795
    [Abstract] [Full Text] [Related]

  • 17. Human papillomavirus mRNA testing for the detection of anal high-grade squamous intraepithelial lesions in men who have sex with men infected with HIV.
    Sendagorta E, Romero MP, Bernardino JI, Beato MJ, Alvarez-Gallego M, Herranz P.
    J Med Virol; 2015 Aug 27; 87(8):1397-403. PubMed ID: 25940055
    [Abstract] [Full Text] [Related]

  • 18. Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women.
    Luttmer R, Berkhof J, Dijkstra MG, van Kemenade FJ, Snijders PJ, Heideman DA, Meijer CJ.
    J Clin Virol; 2015 Jun 27; 67():59-66. PubMed ID: 25959161
    [Abstract] [Full Text] [Related]

  • 19. p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women.
    Giorgi Rossi P, Carozzi F, Ronco G, Allia E, Bisanzi S, Gillio-Tos A, De Marco L, Rizzolo R, Gustinucci D, Del Mistro A, Frayle H, Confortini M, Iossa A, Cesarini E, Bulletti S, Passamonti B, Gori S, Toniolo L, Barca A, Bonvicini L, Mancuso P, Venturelli F, Benevolo M, the New Technology for Cervical Cancer 2 Working Group.
    J Natl Cancer Inst; 2021 Mar 01; 113(3):292-300. PubMed ID: 32745170
    [Abstract] [Full Text] [Related]

  • 20. The clinical value of HPV E6/E7 and STAT3 mRNA detection in cervical cancer screening.
    Fan Y, Shen Z.
    Pathol Res Pract; 2018 May 01; 214(5):767-775. PubMed ID: 29655523
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.